181 related articles for article (PubMed ID: 11383911)
1. Bone mineral density and bone markers in hypogonadotropic and hypergonadotropic hypogonadal men after prolonged testosterone treatment.
De Rosa M; Paesano L; Nuzzo V; Zarrilli S; Del Puente A; Oriente P; Lupoli G
J Endocrinol Invest; 2001 Apr; 24(4):246-52. PubMed ID: 11383911
[TBL] [Abstract][Full Text] [Related]
2. Quantitative bone SPECT in young males with delayed puberty and hypogonadism: implications for treatment of low bone mineral density.
Lubushitzky R; Front D; Iosilevsky G; Bettman L; Frenkel A; Kolodny GM; Israel O
J Nucl Med; 1998 Jan; 39(1):104-7. PubMed ID: 9443746
[TBL] [Abstract][Full Text] [Related]
3. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover.
Guo CY; Jones TH; Eastell R
J Clin Endocrinol Metab; 1997 Feb; 82(2):658-65. PubMed ID: 9024272
[TBL] [Abstract][Full Text] [Related]
4. Klinefelter's syndrome and bone mineral density: is osteoporosis a constant feature?
Hiéronimus S; Lussiez V; Le Duff F; Ferrari P; Bständig B; Fénichel P
Ann Endocrinol (Paris); 2011 Feb; 72(1):14-8. PubMed ID: 21126728
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone.
Bojesen A; Birkebæk N; Kristensen K; Heickendorff L; Mosekilde L; Christiansen JS; Gravholt CH
Osteoporos Int; 2011 May; 22(5):1441-50. PubMed ID: 20658127
[TBL] [Abstract][Full Text] [Related]
6. Bone mass and mineral metabolism in Klinefelter's syndrome.
Luisetto G; Mastrogiacomo I; Bonanni G; Pozzan G; Botteon S; Tizian L; Galuppo P
Osteoporos Int; 1995; 5(6):455-61. PubMed ID: 8695968
[TBL] [Abstract][Full Text] [Related]
7. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.
Katznelson L; Finkelstein JS; Schoenfeld DA; Rosenthal DI; Anderson EJ; Klibanski A
J Clin Endocrinol Metab; 1996 Dec; 81(12):4358-65. PubMed ID: 8954042
[TBL] [Abstract][Full Text] [Related]
8. Site-specific effect of testosterone on bone mineral density in male hypogonadism.
Choi HR; Lim SK; Lee MS
J Korean Med Sci; 1995 Dec; 10(6):431-5. PubMed ID: 8924228
[TBL] [Abstract][Full Text] [Related]
9. Abnormal melatonin secretion in hypogonadal men: the effect of testosterone treatment.
Luboshitzky R; Wagner O; Lavi S; Herer P; Lavie P
Clin Endocrinol (Oxf); 1997 Oct; 47(4):463-9. PubMed ID: 9404445
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density and quantitative ultrasound parameters in patients with Klinefelter's syndrome after long-term testosterone substitution.
van den Bergh JP; Hermus AR; Spruyt AI; Sweep CG; Corstens FH; Smals AG
Osteoporos Int; 2001; 12(1):55-62. PubMed ID: 11305084
[TBL] [Abstract][Full Text] [Related]
11. The clinical significance of bone mineral density and testosterone levels in Korean men with non-mosaic Klinefelter's syndrome.
Seo JT; Lee JS; Oh TH; Joo KJ
BJU Int; 2007 Jan; 99(1):141-6. PubMed ID: 17092285
[TBL] [Abstract][Full Text] [Related]
12. Long-term effect of testosterone replacement therapy on bone in hypogonadal men with Klinefelter Syndrome.
Tahani N; Nieddu L; Prossomariti G; Spaziani M; Granato S; Carlomagno F; Anzuini A; Lenzi A; Radicioni AF; Romagnoli E
Endocrine; 2018 Aug; 61(2):327-335. PubMed ID: 29696556
[TBL] [Abstract][Full Text] [Related]
13. Testosterone treatment in male patients with Klinefelter syndrome: a systematic review and meta-analysis.
Pizzocaro A; Vena W; Condorelli R; Radicioni A; Rastrelli G; Pasquali D; Selice R; Ferlin A; Foresta C; Jannini EA; Maggi M; Lenzi A; Pivonello R; Isidori AM; Garolla A; Francavilla S; Corona G;
J Endocrinol Invest; 2020 Dec; 43(12):1675-1687. PubMed ID: 32567016
[TBL] [Abstract][Full Text] [Related]
14. Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome.
Ferlin A; Selice R; Di Mambro A; Ghezzi M; Di Nisio A; Caretta N; Foresta C
Osteoporos Int; 2015 Aug; 26(8):2193-202. PubMed ID: 25963234
[TBL] [Abstract][Full Text] [Related]
15. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.
Wang C; Eyre DR; Clark R; Kleinberg D; Newman C; Iranmanesh A; Veldhuis J; Dudley RE; Berman N; Davidson T; Barstow TJ; Sinow R; Alexander G; Swerdloff RS
J Clin Endocrinol Metab; 1996 Oct; 81(10):3654-62. PubMed ID: 8855818
[TBL] [Abstract][Full Text] [Related]
16. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
[TBL] [Abstract][Full Text] [Related]
17. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome.
Fairfield WP; Finkelstein JS; Klibanski A; Grinspoon SK
J Clin Endocrinol Metab; 2001 May; 86(5):2020-6. PubMed ID: 11344201
[TBL] [Abstract][Full Text] [Related]
18. The effect of testosterone treatment on bone mineral density in Klinefelter syndrome: A retrospective cohort study.
Willems S; David K; Decallonne B; Marcq P; Antonio L; Vanderschueren D
Andrology; 2023 Oct; 11(7):1295-1302. PubMed ID: 36792918
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density, body composition and bone turnover in patients with congenital hypogonadotropic hypogonadism.
Laitinen EM; Hero M; Vaaralahti K; Tommiska J; Raivio T
Int J Androl; 2012 Aug; 35(4):534-40. PubMed ID: 22248317
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density in hypogonadal men remains low after long-term testosterone replacement.
Ishizaka K; Suzuki M; Kageyama Y; Kihara K; Yoshida K
Asian J Androl; 2002 Jun; 4(2):117-21. PubMed ID: 12085102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
